|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1188 - 0.1364|
|52 Week Range||0.0700 - 1.6500|
|Beta (5Y Monthly)||0.90|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Pure Sunfarms achieves 89% sequential quarterly growth in retail sales volume; maintains leadership in market share in Ontario and low-cost production Vancouver, British Columbia--(Newsfile Corp. - August 13, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") has provided preliminary, unaudited financial results for the second quarter of 2020 for its 41.3%-owned joint venture, Pure Sunfarms."Pure Sunfarms' leadership in low-cost production enables it to offer consumers high-quality cannabis products that are well-priced. ...
Vancouver, British Columbia--(Newsfile Corp. - August 13, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) (the "Company") today announced that it has established an at-the-market equity program ("ATM Program") that allows the Company to issue common shares from treasury ("Common Shares") having an aggregate gross sales price of up to $3.25 million to the public from time to time, at the Company's discretion, at the prevailing market price when issued on the TSX ...
The Digital Issue of the Summer 2020 MicroCap Review Magazine, The Official Magazine for the MicroCap Stock Market, can be read on www.